Found: 123
Select item for more details and to access through your institution.
What's Next for Acute Heart Failure Research?
- Published in:
- Academic Emergency Medicine, 2018, v. 25, n. 1, p. 85, doi. 10.1111/acem.13331
- By:
- Publication type:
- Article
Clinical and Research Considerations for Patients With Hypertensive Acute Heart Failure: A Consensus Statement from the Society for Academic Emergency Medicine and the Heart Failure Society of America Acute Heart Failure Working Group.
- Published in:
- Academic Emergency Medicine, 2016, v. 23, n. 8, p. 922, doi. 10.1111/acem.13025
- By:
- Publication type:
- Article
Early Management of Patients With Acute Heart Failure: State of the Art and Future Directions-A Consensus Document from the SAEM/ HFSA Acute Heart Failure Working Group.
- Published in:
- Academic Emergency Medicine, 2015, v. 22, n. 1, p. 94, doi. 10.1111/acem.12538
- By:
- Publication type:
- Article
Inotropic therapies in heart failure and cardiogenic shock: an educational review.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2021, v. 10, n. 6, p. 676, doi. 10.1093/ehjacc/zuab047
- By:
- Publication type:
- Article
Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113447
- By:
- Publication type:
- Article
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 1, p. 41, doi. 10.1093/eurheartj/ehac530
- By:
- Publication type:
- Article
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 48, p. 5006, doi. 10.1093/eurheartj/ehac293
- By:
- Publication type:
- Article
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 23, p. 2212, doi. 10.1093/eurheartj/ehac144
- By:
- Publication type:
- Article
The struggle towards a Universal Definition of Heart Failure—how to proceed?
- Published in:
- European Heart Journal, 2021, v. 42, n. 24, p. 2331, doi. 10.1093/eurheartj/ehab082
- By:
- Publication type:
- Article
Incorporating development of a patient-reported outcome instrument in a clinical drug development program: examples from a heart failure program.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study.
- Published in:
- European Journal of Health Economics, 2010, v. 11, n. 2, p. 185, doi. 10.1007/s10198-009-0165-2
- By:
- Publication type:
- Article
Neurohormonal Activation in Acute Heart Failure: Results from VERITAS.
- Published in:
- Cardiology, 2011, v. 119, n. 2, p. 96, doi. 10.1159/000330409
- By:
- Publication type:
- Article
Low Lymphocyte Ratio as a Novel Prognostic Factor in Acute Heart Failure: Results from the Pre-RELAX-AHF Study.
- Published in:
- Cardiology, 2011, v. 117, n. 3, p. 190, doi. 10.1159/000321416
- By:
- Publication type:
- Article
Acute Heart Failure Clinical Drug Development: From Planning to Proof of Activity to Phase III.
- Published in:
- Cardiology, 2010, v. 116, n. 4, p. 292, doi. 10.1159/000318048
- By:
- Publication type:
- Article
Cardiac inotropes: current agents and future directions.
- Published in:
- European Heart Journal, 2011, v. 32, n. 15, p. 1838, doi. 10.1093/eurheartj/ehr026
- By:
- Publication type:
- Article
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.
- Published in:
- European Heart Journal, 2011, v. 32, n. 12, p. 1519, doi. 10.1093/eurheartj/ehr042
- By:
- Publication type:
- Article
Effects of tolvaptan on dyspnoea relief from the EVEREST trials.
- Published in:
- European Heart Journal, 2009, v. 30, n. 18, p. 2233
- By:
- Publication type:
- Article
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 17, p. 2009, doi. 10.1001/jama.298.17.2009
- By:
- Publication type:
- Article
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction – Results from the EMPULSE trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 963, doi. 10.1002/ejhf.3218
- By:
- Publication type:
- Article
Effective medications can work only in patients who take them: Implications for post‐acute heart failure care.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 1, doi. 10.1002/ejhf.3109
- By:
- Publication type:
- Article
Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS‐986231).
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 142, doi. 10.1002/ejhf.3077
- By:
- Publication type:
- Article
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSE.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 10, p. 1797, doi. 10.1002/ejhf.2982
- By:
- Publication type:
- Article
Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1584, doi. 10.1002/ejhf.2975
- By:
- Publication type:
- Article
The win ratio method in heart failure trials: lessons learnt from EMPULSE.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 5, p. 632, doi. 10.1002/ejhf.2853
- By:
- Publication type:
- Article
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX‐AHF‐2 trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 541, doi. 10.1002/ejhf.2820
- By:
- Publication type:
- Article
Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 1, p. 35, doi. 10.1002/ejhf.2695
- By:
- Publication type:
- Article
Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1844, doi. 10.1002/ejhf.2681
- By:
- Publication type:
- Article
Worsening renal function in acute heart failure in the context of diuretic response.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 2, p. 365, doi. 10.1002/ejhf.2384
- By:
- Publication type:
- Article
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC‐HF).
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 6, p. 1052, doi. 10.1002/ejhf.2181
- By:
- Publication type:
- Article
Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 5, p. 826, doi. 10.1002/ejhf.2137
- By:
- Publication type:
- Article
Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 4, p. 567, doi. 10.1002/ejhf.2154
- By:
- Publication type:
- Article
The significance of left ventricular ejection time in heart failure with reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 4, p. 541, doi. 10.1002/ejhf.2125
- By:
- Publication type:
- Article
Left ventricular systolic ejection time is an independent predictor of all‐cause mortality in heart failure with reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 2, p. 240, doi. 10.1002/ejhf.2022
- By:
- Publication type:
- Article
Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the RELAX‐AHF‐2 study.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 1, p. 58, doi. 10.1002/ejhf.2012
- By:
- Publication type:
- Article
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2160, doi. 10.1002/ejhf.2015
- By:
- Publication type:
- Article
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Mega-trials in heart failure: effects of dilution in examination of new therapies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo‐controlled trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1684, doi. 10.1002/ejhf.1743
- By:
- Publication type:
- Article
Systolic time intervals in patients with heart failure: time to teach new dogs old tricks.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effects of serelaxin in patients admitted for acute heart failure: a meta-analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Is plasma renin activity associated with worse outcomes in acute heart failure? A secondary analysis from the BLAST-AHF trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Erratum to 'The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963-972].
- Published in:
- 2019
- By:
- Publication type:
- corrected article
The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Sudden cardiac death after acute heart failure hospital admission: insights from ASCEND-HF.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?
- Published in:
- 2018
- By:
- Publication type:
- journal article